SCHEDULE: Barclays Discloses 0.42% Stake in Core Scientific
Beneficial Ownership Disclosure
Barclays PLC has filed an amendment to its Schedule 13G, reporting a passive beneficial ownership of 0.42% in Core Scientific Inc.
Summary
- Barclays PLC reported beneficial ownership of 1,302,387 shares of Core Scientific Inc. common stock.
- This ownership represents 0.42% of the total class of securities.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous disclosure.
- Barclays PLC, a United Kingdom-based entity, holds sole voting power over 1,298,420 shares and shared voting power over 3,967 shares.
- Barclays PLC also holds sole dispositive power over 1,298,420 shares and shared dispositive power over 3,967 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Core Scientific Inc.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of passive beneficial ownership by an institutional investor, with no indication of strategic intent or significant change in the company's outlook.
Management Comments
- Barclays PLC certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors holding less than 5% of a company's stock, indicating passive investment rather than an attempt to influence control. This filing by Barclays PLC is consistent with typical institutional portfolio management.
Stakeholder Impact
- Minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as the reported ownership is passive and below the 5% threshold for significant influence.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of the event which required the filing of this statement. |
| 02/11/2026 | Date of signature for the filing by Barclays PLC. |
Keywords
Barclays PLC, Core Scientific Inc, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.